ALK-positive lung cancer is a relatively rare form of lung cancer caused by the abnormal rearrangement of the anaplastic lymphoma kinase gene. The vast majority of patients are non-smokers, half are under 50 years of age when diagnosed (some are much younger), and the majority are female. Most patients are diagnosed at Stage 4.
We want everyone in the UK who is diagnosed with ALK-positive lung cancer:
To receive the best care possible
To live their best lives possible
To live for as long as possible